Medrx Co., Ltd.
Records under this name other than the patents Medrx Co., Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 25 patents it holds.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 11,267,023 | Hearing device restoration device, system, and methods therefor Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 10,016,502 | Patch Preparation Containing an Acid Scavenger Lapsed on the fee record Ended Jul 10, 2026 · High confidence | Lapsed on the fee record | Ended Jul 10, 2026 | High confidence |
| US 8,623,387 | External preparation composition comprising fatty acid-based ionic liquid as active ingredient Lapsed on the fee record Ended Jan 7, 2026 · From the USPTO record | Lapsed on the fee record | Ended Jan 7, 2026 | From the USPTO record |
| US 11,167,119 | Microneedle patch applicator and housing for same Lapsed on the fee record Ended Nov 9, 2025 · From the USPTO record | Lapsed on the fee record | Ended Nov 9, 2025 | From the USPTO record |
| US 11,141,387 | Memantine-containing transdermally absorbable liquid Lapsed on the fee record Ended Oct 12, 2025 · From the USPTO record | Lapsed on the fee record | Ended Oct 12, 2025 | From the USPTO record |
| US 11,116,953 | Microneedle applicator and microneedle patch application device Lapsed on the fee record Ended Sep 14, 2025 · From the USPTO record | Lapsed on the fee record | Ended Sep 14, 2025 | From the USPTO record |
| US 9,750,924 | Adhesive patching aid for microneedle adhesive skin patch Lapsed on the fee record Ended Sep 5, 2025 · From the USPTO record | Lapsed on the fee record | Ended Sep 5, 2025 | From the USPTO record |
| US 8,697,096 | Tape preparation comprising etodolac in ionic liquid form Lapsed on the fee record Ended Apr 15, 2022 · From the USPTO record | Lapsed on the fee record | Ended Apr 15, 2022 | From the USPTO record |
| US 7,655,687 | Anti-inflammatory analgesic for external use Lapsed on the fee record Ended Feb 2, 2022 · From the USPTO record | Lapsed on the fee record | Ended Feb 2, 2022 | From the USPTO record |
| US 8,815,261 | Composition for external application comprising aripiprazole and organic acid as active ingredients Lapsed on the fee record Ended Aug 26, 2018 · From the USPTO record | Lapsed on the fee record | Ended Aug 26, 2018 | From the USPTO record |